Medipure News

MEDIPURE ANNOUNCES KEY ADDITION TO TAKE COMPANY TO NEXT STAGE OF DEVELOPMENT

Vancouver, BC – February, 2019 - Medipure Holdings Inc., a biopharmaceutical incubator committed to discovering and developing proprietary endocannabinoid system-based prescription drugs for targeted diseases by regulating specific molecular mechanisms, today announced the appointment of Alan C. Mendelson as Corporate Secretary and Advisor to the Board of Directors.

MEDIPURE ANNOUNCES APPOINTMENT OF RENOWNED CROATIAN HEALTH SPECIALIST

Vancouver, BC – February,  2019 - Medipure Holdings Inc., a biopharmaceutical incubator committed to discovering and developing proprietary endocannabinoid system-based prescription drugs for targeted diseases by regulating specific molecular mechanisms, today announced the appointment of Dr. Ognjen Brborović to its Scientific Advisory Board.

MEDIPURE ANNOUNCES KEY APPOINTMENT TO CROATIA SUBSIDIARY

Vancouver, BC – February, 2019 - Medipure Holdings Inc., a biopharmaceutical incubator committed to discovering and developing proprietary endocannabinoid system-based prescription drugs for targeted diseases by regulating specific molecular mechanisms, today announced the appointment of Dr. Miroslav Weiss as Medical Director of its subsidiary in Croatia.

MEDIPURE ANNOUNCES DIRECTOR OF OPERATIONS FOR CROATIAN SUBSIDIARY

Vancouver, BC – October 29, 2018: Medipure Pharmaceuticals Inc., a biopharmaceutical incubator committed to discovering and developing proprietary endocannabinoid system-based prescription drugs for targeted diseases by regulating specific molecular mechanisms, today announced the appointment of Dr. Dubravko Kičić as Director of Operations for its Croatian subsidiary.

MEDIPURE EXPANDS TO CROATIA

Vancouver, BC – Medipure Holdings Inc. is taking another step to advance its research and development by creating a subsidiary, Medipure d.o.o., in Croatia.

The Croatian R&D facility will focus on clinical trials and pharmacology. Along with full analytical labs, this site will house a GMP facility allowing the Company to produce drugs in compliance with the European regulatory standards necessary to support clinical trials on the road to regulatory approvals and commercialization.

MEDIPURE EXPANDS TO INDIA

Vancouver, BC – Medipure Holdings Inc. has taken the next step to advance its research and development by creating a subsidiary, Medipure LifeSciences India (MLSI) Pvt Ltd.

Pages